FindTrial
Sign In

Confirmatory Study of MCC-847 for the treatment of adult asthma.

Confirmatory Study of MCC-847 for the treatment of adult asthma.

Status
Unknown
Phases
Phase 3
Study type
Interventional
Source
JPRN
Registry ID
JPRN-jRCT2080220054
Enrollment
Unknown
Registered
2005-09-08
Start date
2005-09-08
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Adult asthma

Interventions

investigational material(s) Generic name etc : MCC-847 INN of investigational material : Therapeutic category code : 449 Other antiallergic agents Dosage and Administration for Investigational materi

Sponsors

Tanabe Pharma Corporation
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Mild to moderate asthmatic patients aged 16 years and older

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Efficacy (peak expiratory flow rates) and Safety (adverse events)—

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026